{"transactions":[{"id":2544933,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-10-12T20:49:46.000Z","date":"2021-10-09","kind":"tax_withholding","acquired":false,"shares":6470,"price":30.88,"value":199793.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock October 8, 2021."}],"balance_after":264324,"source":{"system":"sec-edgar","filing":"0001219036-21-000031","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000031/edgardoc.xml","form_type":"4"}},{"id":2544932,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-10-12T20:49:46.000Z","date":"2021-10-09","kind":"tax_withholding","acquired":false,"shares":4341,"price":30.88,"value":134050.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 8, 2021."}],"balance_after":270794,"source":{"system":"sec-edgar","filing":"0001219036-21-000031","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000031/edgardoc.xml","form_type":"4"}},{"id":2559319,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-09-27T23:40:18.000Z","date":"2021-09-26","kind":"tax_withholding","acquired":false,"shares":3633,"price":33.31,"value":121015.23,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 24, 2021."}],"balance_after":275135,"source":{"system":"sec-edgar","filing":"0001219036-21-000029","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000029/edgardoc.xml","form_type":"4"}},{"id":2559318,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-09-27T23:40:18.000Z","date":"2021-09-25","kind":"tax_withholding","acquired":false,"shares":9747,"price":33.31,"value":324672.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 24, 2021."}],"balance_after":278768,"source":{"system":"sec-edgar","filing":"0001219036-21-000029","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000029/edgardoc.xml","form_type":"4"}},{"id":2559317,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-09-27T23:40:18.000Z","date":"2021-09-23","kind":"sale","acquired":false,"shares":200,"price":35.06,"value":7012.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":288515,"source":{"system":"sec-edgar","filing":"0001219036-21-000029","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000029/edgardoc.xml","form_type":"4"}},{"id":2561260,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-09-23T21:20:15.000Z","date":"2021-09-21","kind":"grant","acquired":true,"shares":58398,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of performance-based restricted stock units (PSUs) granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. The PSUs were initially granted on October 8, 2020, subject to accomplishment of pre-determined performance metrics.  On September 21, 2021, the Compensation and Human Capital Committee determined the final award amount based on the accomplishment of the applicable performance metrics.  Each PSU represents a contingent right to receive one share of the Company's common stock, and vests 25% on October 9, 2021, 25% on October 9, 2022, 25% on October 9, 2023, and 25% on October 9, 2024."}],"balance_after":288715,"source":{"system":"sec-edgar","filing":"0001219036-21-000027","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000027/edgardoc.xml","form_type":"4"}},{"id":2590050,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-27T01:54:20.000Z","date":"2021-08-25","kind":"tax_withholding","acquired":false,"shares":2233,"price":34.81,"value":77730.73,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on August 25, 2021."}],"balance_after":230317,"source":{"system":"sec-edgar","filing":"0001219036-21-000025","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000025/edgardoc.xml","form_type":"4"}},{"id":2591506,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-08-26T00:32:59.000Z","date":"2021-08-24","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":27.07,"expiration_date":"2022-09-12","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001219036-21-000024","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000024/edgardoc.xml","form_type":"4"}},{"id":2591505,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-08-26T00:32:59.000Z","date":"2021-08-23","kind":"exercise","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option are fully vested and exercisable."}],"balance_after":30000,"derivative":{"exercise_price":27.07,"expiration_date":"2022-09-12","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001219036-21-000024","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000024/edgardoc.xml","form_type":"4"}},{"id":2591504,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-08-26T00:32:59.000Z","date":"2021-08-23","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option are fully vested and exercisable."}],"balance_after":70000,"derivative":{"exercise_price":27.07,"expiration_date":"2022-09-12","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001219036-21-000024","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000024/edgardoc.xml","form_type":"4"}},{"id":2591503,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-26T00:32:59.000Z","date":"2021-08-24","kind":"sale","acquired":false,"shares":30000,"price":35.57,"value":1067100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":232550,"source":{"system":"sec-edgar","filing":"0001219036-21-000024","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000024/edgardoc.xml","form_type":"4"}},{"id":2591502,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-26T00:32:59.000Z","date":"2021-08-24","kind":"exercise","acquired":true,"shares":30000,"price":27.07,"value":812100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":262550,"source":{"system":"sec-edgar","filing":"0001219036-21-000024","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000024/edgardoc.xml","form_type":"4"}},{"id":2591501,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-26T00:32:59.000Z","date":"2021-08-23","kind":"sale","acquired":false,"shares":40000,"price":35.07,"value":1402800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":232550,"source":{"system":"sec-edgar","filing":"0001219036-21-000024","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000024/edgardoc.xml","form_type":"4"}},{"id":2591500,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-26T00:32:59.000Z","date":"2021-08-23","kind":"exercise","acquired":true,"shares":40000,"price":27.07,"value":1082800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":272550,"source":{"system":"sec-edgar","filing":"0001219036-21-000024","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000024/edgardoc.xml","form_type":"4"}},{"id":2591499,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-26T00:32:59.000Z","date":"2021-08-23","kind":"sale","acquired":false,"shares":10000,"price":35.57,"value":355700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":232550,"source":{"system":"sec-edgar","filing":"0001219036-21-000024","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000024/edgardoc.xml","form_type":"4"}},{"id":2591498,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-26T00:32:59.000Z","date":"2021-08-23","kind":"exercise","acquired":true,"shares":10000,"price":27.07,"value":270700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":242550,"source":{"system":"sec-edgar","filing":"0001219036-21-000024","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000024/edgardoc.xml","form_type":"4"}},{"id":2612156,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-08-06T21:47:27.000Z","date":"2021-08-05","kind":"exercise","acquired":false,"shares":28225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option are fully vested and exercisable."}],"balance_after":80000,"derivative":{"exercise_price":27.07,"expiration_date":"2022-09-12","underlying":"Common Stock","underlying_shares":28225},"source":{"system":"sec-edgar","filing":"0001219036-21-000022","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000022/edgardoc.xml","form_type":"4"}},{"id":2612155,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-06T21:47:27.000Z","date":"2021-08-05","kind":"sale","acquired":false,"shares":28225,"price":35.5716,"value":1004008.41,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.57 to $35.60, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":232550,"source":{"system":"sec-edgar","filing":"0001219036-21-000022","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000022/edgardoc.xml","form_type":"4"}},{"id":2612154,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-06T21:47:27.000Z","date":"2021-08-05","kind":"exercise","acquired":true,"shares":28225,"price":27.07,"value":764050.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":260775,"source":{"system":"sec-edgar","filing":"0001219036-21-000022","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000022/edgardoc.xml","form_type":"4"}},{"id":2613704,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-08-05T21:18:01.000Z","date":"2021-08-04","kind":"exercise","acquired":false,"shares":11775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option are fully vested and exercisable."}],"balance_after":108225,"derivative":{"exercise_price":27.07,"expiration_date":"2022-09-12","underlying":"Common Stock","underlying_shares":11775},"source":{"system":"sec-edgar","filing":"0001219036-21-000020","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000020/edgardoc.xml","form_type":"4"}},{"id":2613703,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-08-05T21:18:01.000Z","date":"2021-08-04","kind":"exercise","acquired":false,"shares":38225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option are fully vested and exercisable."}],"balance_after":120000,"derivative":{"exercise_price":27.07,"expiration_date":"2022-09-12","underlying":"Common Stock","underlying_shares":38225},"source":{"system":"sec-edgar","filing":"0001219036-21-000020","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000020/edgardoc.xml","form_type":"4"}},{"id":2613702,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-08-05T21:18:01.000Z","date":"2021-08-03","kind":"exercise","acquired":false,"shares":1775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option are fully vested and exercisable."}],"balance_after":158225,"derivative":{"exercise_price":27.07,"expiration_date":"2022-09-12","underlying":"Common Stock","underlying_shares":1775},"source":{"system":"sec-edgar","filing":"0001219036-21-000020","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000020/edgardoc.xml","form_type":"4"}},{"id":2613701,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-08-05T21:18:01.000Z","date":"2021-08-03","kind":"exercise","acquired":false,"shares":16225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":26.49,"expiration_date":"2021-09-17","underlying":"Common Stock","underlying_shares":16225},"source":{"system":"sec-edgar","filing":"0001219036-21-000020","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000020/edgardoc.xml","form_type":"4"}},{"id":2613700,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-08-05T21:18:01.000Z","date":"2021-08-03","kind":"exercise","acquired":false,"shares":27830,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":23.98,"expiration_date":"2022-03-07","underlying":"Common Stock","underlying_shares":27830},"source":{"system":"sec-edgar","filing":"0001219036-21-000020","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000020/edgardoc.xml","form_type":"4"}},{"id":2613699,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2021-08-05T21:18:01.000Z","date":"2021-08-03","kind":"exercise","acquired":false,"shares":4170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":23.98,"expiration_date":"2022-03-07","underlying":"Common Stock","underlying_shares":4170},"source":{"system":"sec-edgar","filing":"0001219036-21-000020","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000020/edgardoc.xml","form_type":"4"}},{"id":2613698,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-05T21:18:01.000Z","date":"2021-08-04","kind":"sale","acquired":false,"shares":11775,"price":35.5716,"value":418855.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.57 to $35.58, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":232550,"source":{"system":"sec-edgar","filing":"0001219036-21-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000020/edgardoc.xml","form_type":"4"}},{"id":2613697,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-05T21:18:01.000Z","date":"2021-08-04","kind":"exercise","acquired":true,"shares":11775,"price":27.07,"value":318749.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":244325,"source":{"system":"sec-edgar","filing":"0001219036-21-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000020/edgardoc.xml","form_type":"4"}},{"id":2613696,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-05T21:18:01.000Z","date":"2021-08-04","kind":"sale","acquired":false,"shares":38225,"price":35.2432,"value":1347171.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.09 to $35.51, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":232550,"source":{"system":"sec-edgar","filing":"0001219036-21-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000020/edgardoc.xml","form_type":"4"}},{"id":2613695,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-05T21:18:01.000Z","date":"2021-08-04","kind":"exercise","acquired":true,"shares":38225,"price":27.07,"value":1034750.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":270775,"source":{"system":"sec-edgar","filing":"0001219036-21-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000020/edgardoc.xml","form_type":"4"}},{"id":2613694,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-05T21:18:01.000Z","date":"2021-08-03","kind":"sale","acquired":false,"shares":4170,"price":34,"value":141780.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":232550,"source":{"system":"sec-edgar","filing":"0001219036-21-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000020/edgardoc.xml","form_type":"4"}},{"id":2613693,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-05T21:18:01.000Z","date":"2021-08-03","kind":"exercise","acquired":true,"shares":4170,"price":23.98,"value":99996.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":236720,"source":{"system":"sec-edgar","filing":"0001219036-21-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000020/edgardoc.xml","form_type":"4"}},{"id":2613692,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-05T21:18:01.000Z","date":"2021-08-03","kind":"sale","acquired":false,"shares":27830,"price":34,"value":946220.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":232550,"source":{"system":"sec-edgar","filing":"0001219036-21-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000020/edgardoc.xml","form_type":"4"}},{"id":2613691,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-05T21:18:01.000Z","date":"2021-08-03","kind":"exercise","acquired":true,"shares":27830,"price":23.98,"value":667363.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":260380,"source":{"system":"sec-edgar","filing":"0001219036-21-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000020/edgardoc.xml","form_type":"4"}},{"id":2613690,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-05T21:18:01.000Z","date":"2021-08-03","kind":"sale","acquired":false,"shares":1775,"price":35.07,"value":62249.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":232550,"source":{"system":"sec-edgar","filing":"0001219036-21-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000020/edgardoc.xml","form_type":"4"}},{"id":2613689,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-05T21:18:01.000Z","date":"2021-08-03","kind":"exercise","acquired":true,"shares":1775,"price":27.07,"value":48049.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":234325,"source":{"system":"sec-edgar","filing":"0001219036-21-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000020/edgardoc.xml","form_type":"4"}},{"id":2613688,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-05T21:18:01.000Z","date":"2021-08-03","kind":"sale","acquired":false,"shares":16225,"price":33.99,"value":551487.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":232550,"source":{"system":"sec-edgar","filing":"0001219036-21-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000020/edgardoc.xml","form_type":"4"}},{"id":2613687,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-05T21:18:01.000Z","date":"2021-08-03","kind":"exercise","acquired":true,"shares":16225,"price":26.49,"value":429800.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":248775,"source":{"system":"sec-edgar","filing":"0001219036-21-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000020/edgardoc.xml","form_type":"4"}},{"id":2634371,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-07-14T21:44:33.000Z","date":"2021-07-13","kind":"exercise","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to this option are fully vested and exercisable."}],"balance_after":16225,"derivative":{"exercise_price":26.49,"expiration_date":"2021-09-17","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001219036-21-000018","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000018/edgardoc.xml","form_type":"4"}},{"id":2634370,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-07-14T21:44:33.000Z","date":"2021-07-13","kind":"exercise","acquired":false,"shares":3295,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to this option are fully vested and exercisable."}],"balance_after":56225,"derivative":{"exercise_price":26.49,"expiration_date":"2021-09-17","underlying":"Common Stock","underlying_shares":3295},"source":{"system":"sec-edgar","filing":"0001219036-21-000018","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000018/edgardoc.xml","form_type":"4"}},{"id":2634369,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-07-14T21:44:33.000Z","date":"2021-07-12","kind":"exercise","acquired":false,"shares":13295,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to this option are fully vested and exercisable."}],"balance_after":59520,"derivative":{"exercise_price":26.49,"expiration_date":"2021-09-17","underlying":"Common Stock","underlying_shares":13295},"source":{"system":"sec-edgar","filing":"0001219036-21-000018","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000018/edgardoc.xml","form_type":"4"}},{"id":2634368,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-07-14T21:44:33.000Z","date":"2021-07-12","kind":"exercise","acquired":false,"shares":36705,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to this option are fully vested and exercisable."}],"balance_after":72815,"derivative":{"exercise_price":26.49,"expiration_date":"2021-09-17","underlying":"Common Stock","underlying_shares":36705},"source":{"system":"sec-edgar","filing":"0001219036-21-000018","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000018/edgardoc.xml","form_type":"4"}},{"id":2634367,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-07-14T21:44:33.000Z","date":"2021-07-13","kind":"sale","acquired":false,"shares":40000,"price":33.7439,"value":1349756.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.49 to $33.96, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":232550,"source":{"system":"sec-edgar","filing":"0001219036-21-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000018/edgardoc.xml","form_type":"4"}},{"id":2634366,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-07-14T21:44:33.000Z","date":"2021-07-13","kind":"exercise","acquired":true,"shares":40000,"price":26.49,"value":1059600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":272550,"source":{"system":"sec-edgar","filing":"0001219036-21-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000018/edgardoc.xml","form_type":"4"}},{"id":2634365,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-07-14T21:44:33.000Z","date":"2021-07-13","kind":"sale","acquired":false,"shares":3295,"price":33.6909,"value":111011.5155,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.205 to $33.95, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":232550,"source":{"system":"sec-edgar","filing":"0001219036-21-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000018/edgardoc.xml","form_type":"4"}},{"id":2634364,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-07-14T21:44:33.000Z","date":"2021-07-13","kind":"exercise","acquired":true,"shares":3295,"price":26.49,"value":87284.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":235845,"source":{"system":"sec-edgar","filing":"0001219036-21-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000018/edgardoc.xml","form_type":"4"}},{"id":2634363,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-07-14T21:44:33.000Z","date":"2021-07-12","kind":"sale","acquired":false,"shares":13295,"price":33.5521,"value":446075.1695,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.08 to $34.01, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":232550,"source":{"system":"sec-edgar","filing":"0001219036-21-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000018/edgardoc.xml","form_type":"4"}},{"id":2634362,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-07-14T21:44:33.000Z","date":"2021-07-12","kind":"exercise","acquired":true,"shares":13295,"price":26.49,"value":352184.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":245845,"source":{"system":"sec-edgar","filing":"0001219036-21-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000018/edgardoc.xml","form_type":"4"}},{"id":2634361,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-07-14T21:44:33.000Z","date":"2021-07-12","kind":"sale","acquired":false,"shares":36705,"price":33.5494,"value":1231430.727,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.08 to $34.01, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":232550,"source":{"system":"sec-edgar","filing":"0001219036-21-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000018/edgardoc.xml","form_type":"4"}},{"id":2634360,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-07-14T21:44:33.000Z","date":"2021-07-12","kind":"exercise","acquired":true,"shares":36705,"price":26.49,"value":972315.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":269255,"source":{"system":"sec-edgar","filing":"0001219036-21-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000018/edgardoc.xml","form_type":"4"}},{"id":2636497,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-07-12T22:16:38.000Z","date":"2021-07-09","kind":"exercise","acquired":false,"shares":5603,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option are fully vested and exercisable."}],"balance_after":109520,"derivative":{"exercise_price":26.49,"expiration_date":"2021-09-17","underlying":"Common Stock","underlying_shares":5603},"source":{"system":"sec-edgar","filing":"0001219036-21-000016","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000016/edgardoc.xml","form_type":"4"}},{"id":2636496,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-07-12T22:16:38.000Z","date":"2021-07-09","kind":"exercise","acquired":false,"shares":26705,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option are fully vested and exercisable."}],"balance_after":115123,"derivative":{"exercise_price":26.49,"expiration_date":"2021-09-17","underlying":"Common Stock","underlying_shares":26705},"source":{"system":"sec-edgar","filing":"0001219036-21-000016","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000016/edgardoc.xml","form_type":"4"}},{"id":2636495,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-07-12T22:16:38.000Z","date":"2021-07-09","kind":"exercise","acquired":false,"shares":17692,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":19.47,"expiration_date":"2021-09-13","underlying":"Common Stock","underlying_shares":17692},"source":{"system":"sec-edgar","filing":"0001219036-21-000016","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000016/edgardoc.xml","form_type":"4"}},{"id":2636494,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-07-12T22:16:38.000Z","date":"2021-07-09","kind":"sale","acquired":false,"shares":17692,"price":32.47,"value":574459.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":232550,"source":{"system":"sec-edgar","filing":"0001219036-21-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000016/edgardoc.xml","form_type":"4"}},{"id":2636493,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-07-12T22:16:38.000Z","date":"2021-07-09","kind":"exercise","acquired":true,"shares":17692,"price":19.47,"value":344463.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":250242,"source":{"system":"sec-edgar","filing":"0001219036-21-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000016/edgardoc.xml","form_type":"4"}},{"id":2636492,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-07-12T22:16:38.000Z","date":"2021-07-09","kind":"sale","acquired":false,"shares":5603,"price":32.29,"value":180920.87,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":232550,"source":{"system":"sec-edgar","filing":"0001219036-21-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000016/edgardoc.xml","form_type":"4"}},{"id":2636491,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-07-12T22:16:38.000Z","date":"2021-07-09","kind":"exercise","acquired":true,"shares":5603,"price":26.49,"value":148423.47,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":238153,"source":{"system":"sec-edgar","filing":"0001219036-21-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000016/edgardoc.xml","form_type":"4"}},{"id":2636490,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-07-12T22:16:38.000Z","date":"2021-07-09","kind":"sale","acquired":false,"shares":26705,"price":32.79,"value":875656.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":232550,"source":{"system":"sec-edgar","filing":"0001219036-21-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000016/edgardoc.xml","form_type":"4"}},{"id":2636489,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-07-12T22:16:38.000Z","date":"2021-07-09","kind":"exercise","acquired":true,"shares":26705,"price":26.49,"value":707415.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":259255,"source":{"system":"sec-edgar","filing":"0001219036-21-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000016/edgardoc.xml","form_type":"4"}},{"id":2638779,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-07-08T21:50:44.000Z","date":"2021-07-07","kind":"exercise","acquired":false,"shares":30424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option are fully vested and exercisable."}],"balance_after":141828,"derivative":{"exercise_price":26.49,"expiration_date":"2021-09-17","underlying":"Common Stock","underlying_shares":30424},"source":{"system":"sec-edgar","filing":"0001219036-21-000014","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000014/edgardoc.xml","form_type":"4"}},{"id":2638778,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2021-07-08T21:50:44.000Z","date":"2021-07-07","kind":"exercise","acquired":false,"shares":1884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":26.49,"expiration_date":"2021-09-17","underlying":"Common Stock","underlying_shares":1884},"source":{"system":"sec-edgar","filing":"0001219036-21-000014","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000014/edgardoc.xml","form_type":"4"}},{"id":2638777,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-07-08T21:50:44.000Z","date":"2021-07-07","kind":"sale","acquired":false,"shares":1884,"price":31.99,"value":60269.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":232550,"source":{"system":"sec-edgar","filing":"0001219036-21-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000014/edgardoc.xml","form_type":"4"}},{"id":2638776,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-07-08T21:50:44.000Z","date":"2021-07-07","kind":"exercise","acquired":true,"shares":1884,"price":26.49,"value":49907.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":234434,"source":{"system":"sec-edgar","filing":"0001219036-21-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000014/edgardoc.xml","form_type":"4"}},{"id":2638775,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-07-08T21:50:44.000Z","date":"2021-07-07","kind":"sale","acquired":false,"shares":30424,"price":32.29,"value":982390.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":232550,"source":{"system":"sec-edgar","filing":"0001219036-21-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000014/edgardoc.xml","form_type":"4"}},{"id":2638774,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-07-08T21:50:44.000Z","date":"2021-07-07","kind":"exercise","acquired":true,"shares":30424,"price":26.49,"value":805931.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":262974,"source":{"system":"sec-edgar","filing":"0001219036-21-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000014/edgardoc.xml","form_type":"4"}},{"id":2650814,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-06-30T21:50:20.000Z","date":"2021-06-28","kind":"exercise","acquired":false,"shares":3973,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to this option are fully vested and exercisable."}],"balance_after":172252,"derivative":{"exercise_price":26.49,"expiration_date":"2021-09-17","underlying":"Common Stock","underlying_shares":3973},"source":{"system":"sec-edgar","filing":"0001219036-21-000012","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000012/edgardoc.xml","form_type":"4"}},{"id":2650813,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-06-30T21:50:20.000Z","date":"2021-06-28","kind":"exercise","acquired":false,"shares":948,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to this option are fully vested and exercisable."}],"balance_after":17692,"derivative":{"exercise_price":19.47,"expiration_date":"2021-09-13","underlying":"Common Stock","underlying_shares":948},"source":{"system":"sec-edgar","filing":"0001219036-21-000012","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000012/edgardoc.xml","form_type":"4"}},{"id":2650812,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2021-06-30T21:50:20.000Z","date":"2021-06-28","kind":"exercise","acquired":false,"shares":1891,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to this option are fully vested and exercisable."}],"balance_after":1884,"derivative":{"exercise_price":26.49,"expiration_date":"2021-09-17","underlying":"Common Stock","underlying_shares":1891},"source":{"system":"sec-edgar","filing":"0001219036-21-000012","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000012/edgardoc.xml","form_type":"4"}},{"id":2650811,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-06-30T21:50:20.000Z","date":"2021-06-28","kind":"sale","acquired":false,"shares":948,"price":32.4937,"value":30804.0276,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.48 to $32.50, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":232550,"source":{"system":"sec-edgar","filing":"0001219036-21-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000012/edgardoc.xml","form_type":"4"}},{"id":2650810,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-06-30T21:50:20.000Z","date":"2021-06-28","kind":"exercise","acquired":true,"shares":948,"price":19.47,"value":18457.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":233498,"source":{"system":"sec-edgar","filing":"0001219036-21-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000012/edgardoc.xml","form_type":"4"}},{"id":2650809,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-06-30T21:50:20.000Z","date":"2021-06-28","kind":"sale","acquired":false,"shares":1891,"price":32.2314,"value":60949.5774,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.99 to $32.50, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":232550,"source":{"system":"sec-edgar","filing":"0001219036-21-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000012/edgardoc.xml","form_type":"4"}},{"id":2650808,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-06-30T21:50:20.000Z","date":"2021-06-28","kind":"exercise","acquired":true,"shares":1891,"price":26.49,"value":50092.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":234441,"source":{"system":"sec-edgar","filing":"0001219036-21-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000012/edgardoc.xml","form_type":"4"}},{"id":2650807,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-06-30T21:50:20.000Z","date":"2021-06-28","kind":"sale","acquired":false,"shares":3973,"price":32.4326,"value":128854.7198,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.30 to $32.72, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":232550,"source":{"system":"sec-edgar","filing":"0001219036-21-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000012/edgardoc.xml","form_type":"4"}},{"id":2650806,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-06-30T21:50:20.000Z","date":"2021-06-28","kind":"exercise","acquired":true,"shares":3973,"price":26.49,"value":105244.77,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":236523,"source":{"system":"sec-edgar","filing":"0001219036-21-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000012/edgardoc.xml","form_type":"4"}},{"id":2654114,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-06-29T00:00:59.000Z","date":"2021-06-25","kind":"exercise","acquired":false,"shares":28640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option are fully vested and exercisable."}],"balance_after":18640,"derivative":{"exercise_price":19.47,"expiration_date":"2021-09-13","underlying":"Common Stock","underlying_shares":28640},"source":{"system":"sec-edgar","filing":"0001219036-21-000010","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000010/edgardoc.xml","form_type":"4"}},{"id":2654113,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-06-29T00:00:59.000Z","date":"2021-06-25","kind":"exercise","acquired":false,"shares":21360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option are fully vested and exercisable."}],"balance_after":47280,"derivative":{"exercise_price":19.47,"expiration_date":"2021-09-13","underlying":"Common Stock","underlying_shares":21360},"source":{"system":"sec-edgar","filing":"0001219036-21-000010","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000010/edgardoc.xml","form_type":"4"}},{"id":2654112,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-06-29T00:00:59.000Z","date":"2021-06-25","kind":"sale","acquired":false,"shares":33372,"price":31.6144,"value":1055035.7568,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.30 to $31.99, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":232550,"source":{"system":"sec-edgar","filing":"0001219036-21-000010","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000010/edgardoc.xml","form_type":"4"}},{"id":2654111,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-06-29T00:00:59.000Z","date":"2021-06-25","kind":"sale","acquired":false,"shares":28640,"price":31.97,"value":915620.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":265922,"source":{"system":"sec-edgar","filing":"0001219036-21-000010","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000010/edgardoc.xml","form_type":"4"}},{"id":2654110,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-06-29T00:00:59.000Z","date":"2021-06-25","kind":"exercise","acquired":true,"shares":28640,"price":19.47,"value":557620.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":294562,"source":{"system":"sec-edgar","filing":"0001219036-21-000010","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000010/edgardoc.xml","form_type":"4"}},{"id":2654109,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-06-29T00:00:59.000Z","date":"2021-06-25","kind":"sale","acquired":false,"shares":21360,"price":32.47,"value":693559.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":265922,"source":{"system":"sec-edgar","filing":"0001219036-21-000010","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000010/edgardoc.xml","form_type":"4"}},{"id":2654108,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-06-29T00:00:59.000Z","date":"2021-06-25","kind":"exercise","acquired":true,"shares":21360,"price":19.47,"value":415879.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":287282,"source":{"system":"sec-edgar","filing":"0001219036-21-000010","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000010/edgardoc.xml","form_type":"4"}},{"id":2728262,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-05-05T23:45:58.000Z","date":"2021-05-04","kind":"exercise","acquired":false,"shares":19360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option are fully vested and exercisable."}],"balance_after":68640,"derivative":{"exercise_price":19.47,"expiration_date":"2021-09-13","underlying":"Common Stock","underlying_shares":19360},"source":{"system":"sec-edgar","filing":"0001219036-21-000008","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000008/edgardoc.xml","form_type":"4"}},{"id":2728261,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-05-05T23:45:58.000Z","date":"2021-05-04","kind":"sale","acquired":false,"shares":19360,"price":31.9705,"value":618948.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.97 to $31.98, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":265922,"source":{"system":"sec-edgar","filing":"0001219036-21-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000008/edgardoc.xml","form_type":"4"}},{"id":2728260,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-05-05T23:45:58.000Z","date":"2021-05-04","kind":"exercise","acquired":true,"shares":19360,"price":19.47,"value":376939.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":285282,"source":{"system":"sec-edgar","filing":"0001219036-21-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000008/edgardoc.xml","form_type":"4"}},{"id":2737694,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-04-28T21:10:33.000Z","date":"2021-04-27","kind":"exercise","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option are fully vested and exercisable."}],"balance_after":88000,"derivative":{"exercise_price":19.47,"expiration_date":"2021-09-13","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001219036-21-000006","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000006/edgardoc.xml","form_type":"4"}},{"id":2737693,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-04-28T21:10:33.000Z","date":"2021-04-27","kind":"sale","acquired":false,"shares":40000,"price":31.47,"value":1258800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":265922,"source":{"system":"sec-edgar","filing":"0001219036-21-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000006/edgardoc.xml","form_type":"4"}},{"id":2737692,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-04-28T21:10:33.000Z","date":"2021-04-27","kind":"exercise","acquired":true,"shares":40000,"price":19.47,"value":778800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":305922,"source":{"system":"sec-edgar","filing":"0001219036-21-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000006/edgardoc.xml","form_type":"4"}},{"id":2771107,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-03-26T20:30:01.000Z","date":"2021-03-24","kind":"grant","acquired":true,"shares":19347,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":265922,"source":{"system":"sec-edgar","filing":"0001219036-21-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000004/edgardoc.xml","form_type":"4"}},{"id":2856148,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-02-17T23:10:02.000Z","date":"2021-02-16","kind":"exercise","acquired":false,"shares":74445,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25%  annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations."}],"balance_after":0,"derivative":{"exercise_price":18,"expiration_date":"2021-02-23","underlying":"Common Stock","underlying_shares":74445},"source":{"system":"sec-edgar","filing":"0001219036-21-000002","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000002/edgardoc.xml","form_type":"4"}},{"id":2856147,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2021-02-17T23:10:02.000Z","date":"2021-02-16","kind":"exercise","acquired":false,"shares":5555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25%  annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations."}],"balance_after":0,"derivative":{"exercise_price":18,"expiration_date":"2021-02-23","underlying":"Common Stock","underlying_shares":5555},"source":{"system":"sec-edgar","filing":"0001219036-21-000002","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000002/edgardoc.xml","form_type":"4"}},{"id":2856146,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-02-17T23:10:02.000Z","date":"2021-02-16","kind":"sale","acquired":false,"shares":5555,"price":29.7131,"value":165056.2705,"ownership":{"direct":true},"balance_after":246575,"source":{"system":"sec-edgar","filing":"0001219036-21-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000002/edgardoc.xml","form_type":"4"}},{"id":2856145,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-02-17T23:10:02.000Z","date":"2021-02-16","kind":"exercise","acquired":true,"shares":5555,"price":18,"value":99990.0,"ownership":{"direct":true},"balance_after":252130,"source":{"system":"sec-edgar","filing":"0001219036-21-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000002/edgardoc.xml","form_type":"4"}},{"id":2856144,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-02-17T23:10:02.000Z","date":"2021-02-16","kind":"sale","acquired":false,"shares":74445,"price":29.7131,"value":2211991.7295,"ownership":{"direct":true},"balance_after":246575,"source":{"system":"sec-edgar","filing":"0001219036-21-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000002/edgardoc.xml","form_type":"4"}},{"id":2856143,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-02-17T23:10:02.000Z","date":"2021-02-16","kind":"exercise","acquired":true,"shares":74445,"price":18,"value":1340010.0,"ownership":{"direct":true},"balance_after":321020,"source":{"system":"sec-edgar","filing":"0001219036-21-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903621000002/edgardoc.xml","form_type":"4"}},{"id":3008748,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-10-13T12:06:14.000Z","date":"2020-10-08","kind":"grant","acquired":true,"shares":39196,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on October 9, 2021, 25% on October 9, 2022, 25% on October 9, 2023, and 25% on October 9, 2024."}],"balance_after":246575,"source":{"system":"sec-edgar","filing":"0001219036-20-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903620000008/edgardoc.xml","form_type":"4"}},{"id":3019133,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-10-01T21:30:24.000Z","date":"2020-09-30","kind":"disposition_to_issuer","acquired":false,"shares":5544,"price":13.04,"value":72293.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person."}],"balance_after":207379,"source":{"system":"sec-edgar","filing":"0001219036-20-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903620000006/edgardoc.xml","form_type":"4"}},{"id":3021912,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-09-28T16:47:26.000Z","date":"2020-09-26","kind":"disposition_to_issuer","acquired":false,"shares":3627,"price":12.44,"value":45119.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person."}],"balance_after":212923,"source":{"system":"sec-edgar","filing":"0001219036-20-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903620000004/edgardoc.xml","form_type":"4"}},{"id":3021911,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-09-28T16:47:26.000Z","date":"2020-09-25","kind":"disposition_to_issuer","acquired":false,"shares":4214,"price":12.44,"value":52422.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person."}],"balance_after":216550,"source":{"system":"sec-edgar","filing":"0001219036-20-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903620000004/edgardoc.xml","form_type":"4"}},{"id":3021910,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-09-28T16:47:26.000Z","date":"2020-09-25","kind":"disposition_to_issuer","acquired":false,"shares":5544,"price":12.44,"value":68967.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person."}],"balance_after":220764,"source":{"system":"sec-edgar","filing":"0001219036-20-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903620000004/edgardoc.xml","form_type":"4"}},{"id":3021909,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-09-28T16:47:26.000Z","date":"2020-09-24","kind":"grant","acquired":true,"shares":32800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of performance stock units granted pursuant to the Companys 2017 Employee, Director and Consultant Equity Incentive Plan.  Performance stock units initially granted on September 25, 2019, subject to accomplishment of pre-determined financial performance requirements.  On September 24, 2020, the Compensation Committee determined the final award amount based on the accomplishment of the applicable financial performance requirements.  Each performance stock unit represents a contingent right to receive one share of the Companys common stock, and vests 25% on September 26, 2020, 25% on September 26, 2021, 25% on September 26, 2022, and 25% on September 26, 2023."}],"balance_after":226308,"source":{"system":"sec-edgar","filing":"0001219036-20-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903620000004/edgardoc.xml","form_type":"4"}},{"id":3056442,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":131346,"kind":"person","name":"LANCHBURY JERRY S","position":1,"cik":"0001219036","reported_name":"LANCHBURY JERRY S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-08-17T20:25:30.000Z","date":"2020-08-12","kind":"grant","acquired":true,"shares":10068,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 50% on August 25, 2021, and 50% on August 25, 2022."}],"balance_after":193508,"source":{"system":"sec-edgar","filing":"0001219036-20-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000121903620000002/edgardoc.xml","form_type":"4"}}],"next_cursor":"2020-08-17T20:25:30.000000Z,3056442"}